Advanced search
Publication Cover
Biostatistics & Epidemiology Volume 8, 2024 - Issue 1
Submit an article Journal homepage
159
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Analysis and prediction of omicron infection cases daily in the United Kingdom in November and December 2021

Liming Xiea Department of Statistics, North Dakota State University, Fargo, ND, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7745-5260View further author information
ORCID Icon,
Xiyu Dengb Department of Internal Medicine, 1st Hospital of Wuchang, Wuhan, People’s Republic of ChinaView further author information
,
Xiaoyan Xiec Wuchang Center for Disease Control and Prevention, Wuhan, People’s Republic of ChinaView further author information
&
Shanshan Hud Department of Statistics, Rutgers University, New Brunswick, NJ, USAView further author information
Article: e2340163 | Received 27 Aug 2023, Accepted 02 Apr 2024, Published online: 25 May 2024

References

  • UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England Technical briefing 40, 8 April 2022.
  • Ewen C, Heidi L. How bad is omicron? what scientists know so far. Nat News. 2021;600, 2021: 197–199.
  • Shabir MA, Gaurav K, et al. Population immunity and COVID-19 severity with omicron variant in South Africa. N Engl J Med 2022 Apr 7; 386 (14): 1314–1326.
  • Tommy N, Neil FM, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399:1303–1312. doi:10.1016/S0140-6736(22)00462-7
  • Alexander LL, Ramon L-R, et al. Has omicron changed the evolution of the pandemic? JMIR Public Health Surveill. 2022;8(1):e35763, doi:10.2196/35763
  • Liming X. The analysis and forecasting COVID-19 cases in the United States using Bayesian structural time series models. Biostat Epidemiol. 2021;6(1):1–15. doi:10.1080/24709360.2021.1948380.
  • Debmalya R. New omicron variant- time series analysis. Dev Genius 2022, Apr 3.
  • Emma AK, Katherine F-DE, et al. Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 omicron and delta variants. JAMA. 2022;327(7):639–651. doi:10.1001/jama.2022.0470
  • Champredon D, Dushoff J, Earn David JD. Equivalence of the erlang-distributed SEIR epidemic model and the renewal equation. SIAM J Appl Math. 2018;78(6):3258–3278. doi:10.1137/18M1186411
  • UK Health Security Agency. COVID-19: Omicron daily overview, Details, 2021. https://www.gov.uk/government/publications/covid-19-omicron-daily-overview.
  • World population review. United Kingdom population. 2022 (Live). 2022.
  • Frederic G, Marek K, et al. The spread of SARS-CoV-2 variant omicron with a doubling time of 2.0–3.3 days can be explained by immune evasion. MDPI Viruses. 2022;14:294, doi:10.3390/v14020294
  • Reuters. Omicron hospitalization risks around one third of Delta, UK. Healthcare and Pharmaceuticals. 2021, December 31.
  • Ranjan R. Omicron impact in India: analysis of the ongoing COVID-19 third wave based on global data. medRxiv. 2022. doi: 10.1101/2022.01.09.22268969
  • Lewnard A, Hong V, et al. Clinical outcomes among patients infected with omicron (B.1.1.529) SARS-CoV-2 variant in southern California. medRxiv. 2022;28(9):1933–1943.
  • Cristina M, Anna VM, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID study. Lancet. 2021;399(10335): 1618–1624. doi: 10.1016/S0140-6736(22)00327-0.
  • Max K. Does omicron hit kids harder? scientists are trying to find out. Nat News. 2022. doi:10.1038/d41586-022-00309-x.
  • Nicole W, Waasila J, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399:437–446.
  • Yamin S, Wenchao L, et al. Origin and evolutionary analysis of the SARS-CoV-2 omicron variant. J Biosaf Biosecurity. 2022;4(1):33–37.
  • William HS, Elizabeth M, et al. Generation time of the alpha and delta SAR-CoV-2 variants: an epidemiological analysis. Lancet Infect Dis. 2022;22(5):603–610. doi:10.1016/S1473-3099(22)00001-9
  • Nick A, Stowe J, et al. COVID-19 vaccine effectiveness against the omicron (B.1.1.529) variant. N Engl J Med. 2022;386(16):1532–1546. doi:10.1056/NEJMoa2119451

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.